Clinical trial
Cross-Over Trial to Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancer
NCT06385847 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Xiamen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cross-Over Trial to Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancer
- Lead sponsor
- The First Affiliated Hospital of Xiamen University
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- May 31, 2024
- Completion date
- December 31, 2025
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer